Onward Medical Statistics

Total Valuation

Onward Medical has a market cap or net worth of EUR 184.76 million. The enterprise value is 170.02 million.

Market Cap	184.76M
Enterprise Value	170.02M

Important Dates

The last earnings date was Monday, March 31, 2025.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Onward Medical has 44.63 million shares outstanding. The number of shares has increased by 7.55% in one year.

Current Share Class	n/a
Shares Outstanding	44.63M
Shares Change (YoY)	+7.55%
Shares Change (QoQ)	+14.72%
Owned by Insiders (%)	6.45%
Owned by Institutions (%)	15.84%
Float	26.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	7.81
P/TBV Ratio	22.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.84
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.89

Financial Position

The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.94.

Current Ratio	3.65
Quick Ratio	3.37
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	-0.60
Interest Coverage	-38.55

Financial Efficiency

Return on equity (ROE) is -133.61% and return on invested capital (ROIC) is -51.63%.

Return on Equity (ROE)	-133.61%
Return on Assets (ROA)	-41.83%
Return on Invested Capital (ROIC)	-51.63%
Return on Capital Employed (ROCE)	-94.96%
Revenue Per Employee	-1,899
Profits Per Employee	-355,061
Employee Count	99
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.72% in the last 52 weeks. The beta is 0.85, so Onward Medical's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-2.72%
50-Day Moving Average	5.56
200-Day Moving Average	5.19
Relative Strength Index (RSI)	28.65
Average Volume (20 Days)	75,699

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Onward Medical had revenue of EUR -188,000 and -35.15 million in losses. Loss per share was -1.09.

Revenue	-188,000
Gross Profit	-13.63M
Operating Income	-35.43M
Pretax Income	-35.41M
Net Income	-35.15M
EBITDA	-35.10M
EBIT	-35.43M
Loss Per Share	-1.09

Full Income Statement

Balance Sheet

The company has 32.05 million in cash and 17.31 million in debt, giving a net cash position of 14.74 million or 0.33 per share.

Cash & Cash Equivalents	32.05M
Total Debt	17.31M
Net Cash	14.74M
Net Cash Per Share	0.33
Equity (Book Value)	18.35M
Book Value Per Share	0.53
Working Capital	25.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.68 million and capital expenditures -159,000, giving a free cash flow of -28.84 million.

Operating Cash Flow	-28.68M
Capital Expenditures	-159,000
Free Cash Flow	-28.84M
FCF Per Share	-0.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	18,846.81%
Pretax Margin	18,833.51%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Onward Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.55%
Shareholder Yield	-7.55%
Earnings Yield	-19.02%
FCF Yield	-15.61%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Onward Medical has an Altman Z-Score of -3.84. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.84
Piotroski F-Score	n/a